Certain device manufacturers and clinical laboratories will get a reprieve, and lower- to middle-income families will have to pay less out of pocket under an amended version of a Senate health reform bill introduced this morning on Capitol Hill.
Modified reform bill gives a break to devicemakers, families
The bill, written by Senate Finance Committee Max Baucus (D-Mont.), lowers the maximum penalty for families at a certain income range who choose not to buy health coverage, increases a tax to 40% from 35% on high-value health plans and increases a fee on insurance companies to $6.7 billion per year from $6 billion.
The modified bill would exempt sales of Class II devices—such as extended-wear contact lenses and some hearing aids—that are sold at retail for up to $100 per unit, and exempt all Class I devices, such as bandages and gloves, from a tax on manufacturers. Still, the tax is expected to raise $29.9 billion over the next 10 years. Additionally, the amended bill also eliminates a clinical laboratories fee, replacing it with a temporary reduction in the Medicare laboratory test fee schedule.
“This modification incorporates important ideas from my colleagues on both sides of the aisle,” Baucus said in a written statement. “Crafting a bill that addresses all of the concerns of our broken healthcare system is no easy task, and I'm confidant that, working together, we are even closer to that goal today.”
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.